Esperion Therapeutics Inc. | Balance Sheet
Fiscal year is January-December. All values USD Thousands.
2013
2014
2015
2016
2017
2018
Cash & Short Term Investments
60,062.50
105,841.00
212,261.00
211,583.00
200,199.00
136,023
Other Current Assets
557.20
826.00
2,133.00
1,994.00
3,725.00
6,609
Total Current Assets
60,619.60
106,667.00
214,394.00
213,577.00
203,924.00
142,632
Net Property, Plant & Equipment
80.80
780.00
807.00
674.00
435.00
520
Total Investments and Advances
17,537.70
35,741.00
80,315.00
30,906.00
73,420.00
243
Intangible Assets
55.70
56.00
56.00
56.00
56.00
56
Other Assets
-
100.00
-
-
-
-
Total Assets
78,293.90
143,344.00
295,572.00
245,213.00
277,835.00
143,451
ST Debt & Current Portion LT Debt
-
638.00
1,604.00
1,709.00
1,045.00
Accounts Payable
2,231.90
-
-
-
20,375.00
Other Current Liabilities
1,970.60
4,853.00
4,021.00
13,880.00
11,724.00
Total Current Liabilities
4,202.50
5,491.00
5,625.00
15,589.00
33,144.00
Long-Term Debt
-
4,299.00
2,688.00
1,022.00
-
Total Liabilities
4,202.50
9,790.00
8,313.00
16,611.00
33,144.00
Common Equity (Total)
74,091.40
133,554.00
287,259.00
228,602.00
244,691.00
Total Shareholders' Equity
74,091.40
133,554.00
287,259.00
228,602.00
244,691.00
Total Equity
74,091.40
133,554.00
287,259.00
228,602.00
244,691.00
Liabilities & Shareholders' Equity
78,293.90
143,344.00
295,572.00
245,213.00
277,835.00
About Esperion Therapeutics
View Profile
